Using the 'Support' online training and peer program for adults with type 1 diabetes
Official title: Using the Support Online Platform for Self-management Education of Adults Living With Type 1 Diabetes as Part of Usual Care or Independently: an Implementation Study
Run by McGill University · NCT06069583 · Data updated 2026-11-12
This project will test whether adults with type 1 diabetes who get access to the online 'Support' training and peer platform through their diabetes clinic manage their diabetes better than those who use the platform on their own.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 322 (estimated) |
| Sponsor | McGill University Academic / other |
| Locations | 4 sites (Montreal, Quebec and 3 other locations) |
| Status | Recruiting |
| Started | May 5, 2024 |
| Main results expected | May 5, 2027 |
| Study ends | October 2027 |
| Registry record updated | September 25, 2025 |
| Trial ID | NCT06069583 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults in Canada with a diagnosis of type 1 diabetes (including LADA), who can read English or French, have internet access and an active email address, and are able to use the online platform are ideal candidates.
✕Probably not a fit
People without reliable internet or who are unable to use the online platform, those who prefer only in-person education, or patients with severe cognitive or sensory impairments may not benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This mixed-method, multi-centre trial compares two ways of using an online training and peer support platform called 'Support' — one arm where diabetes clinics integrate and refer patients to the platform, and another arm where adults with T1D access the platform independently. Adults with T1D living in Canada will have 12 months of access and complete online questionnaires at baseline, 6 months and 12 months, and will share glucose reader data with the research team. A subgroup of participants and healthcare professionals from four Quebec clinics will take part in individual interviews to identify barriers and facilitators to integrating 'Support' into routine care. The study combines effectiveness outcomes on self-management and glycemic data with implementation measures to understand both patient benefit and real-world adoption.
Why it matters
Potential benefit: If successful, integrating 'Support' into routine care could improve self-management skills, glucose control (A1c), and patient access to up-to-date education and peer support.
How similar studies have gone: Previous diabetes self-management education programs and some online peer-support interventions have shown improvements in self-management and A1c in adults with diabetes, but results vary and real-world implementation has been inconsistent.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of T1D (including LADA - latent autoimmune diabetes in adults) * Have access to Internet * Use of an active email address * Comprehension of English or French * Live in Canada Exclusion Criteria: \- Unable to use the Support platform
Where it's running
-
Institut de recherches cliniques de Montréal
Montreal, Quebec, Canada Recruiting -
Centre hospitalier de l'université de Montreal
Montreal, Quebec, Canada Recruiting -
Centre hospitalier de Quebec, Université Laval
Québec, Quebec, Canada Recruiting -
Centre de médecine métabolique de Lanaudière
Terrebonne, Quebec, Canada Recruiting
Study contacts
- Principal investigator: Anne-Sophie Brazeau, PhD — School of human nutrition - McGill University
- Study coordinator: Anne-Sophie Brazeau, PhD
- Email: anne-sophie.brazeau@mcgill.ca
- Phone: 5143987848
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Investigating the safety and effectiveness of porcine pancreatic cells in patients with Type 1 diabetes
This study is testing if using pig pancreas cells can help adults with tough-to-manage Type 1 diabetes feel better and avoid dangerous low blood sugar episodes.
-
ETHY-001 safety and activity in Thyroid Eye Disease (TED)
This study tests ETHY-001 versus placebo to see if it is safe, tolerable, and shows activity in people with thyroid eye disease.
-
AMX0035 in adults with Type 1 Diabetes
This study tests whether 24 weeks of the oral medication AMX0035 help improves metabolic health in adults with Type 1 Diabetes compared with a placebo.
-
Insulin delivery technology and eating behaviours in people with type 1 diabetes
This project will test whether automated insulin delivery systems change eating behaviours and make carbohydrate counting easier for people aged 12 and older who have type 1 diabetes in Canada.
-
Real-time continuous glucose monitoring for young adults at risk of DKA
This project will try a Dexcom G6 real-time continuous glucose monitor to see if it helps 18-25-year-olds with insulin-treated diabetes who have poor blood sugar control or recent hospital admissions for high blood sugar.
-
Music-4-MS: A 12-week music-based program to support thinking skills in people with MS
A 12-week music-based program is tested to see if it helps cognitive function and mood in people living with multiple sclerosis.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.